Main image

PROLOR Biotech Reports Positive Results From Comparative Study Of Its Longer-Acting Version Of Multiple Sclerosis Drug Interferon Beta In Primates

26th January
2010
written by Multiple Sclerosis News From Medical News Today

PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) reported positive results from a comparative study in primates of its longer-acting version of the multiple sclerosis drug interferon beta (IFN-beta-1a-CTP, referred to as IFN-beta-CTP)…

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • email
  • Print
  • StumbleUpon
  • YahooMyWeb
Multiple Sclerosis

Leave a Reply